Dow Up 0.41% Nasdaq Up 1.23%
Streaming
Ticker Tape: On

More On ASM.L

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Antisoma PLC (ASM.L)

-LSE

1.44 Down 0.14(8.57%) 11:17AM EDT

Add to Portfolio
Prev Close:1.58
Open:1.50
Bid:1.39
Ask:1.41
1y Target Est:17.00
Beta:N/A
Next Earnings Date:N/A
Day's Range:1.40 - 1.50
52wk Range:1.30 - 2.10
Volume:890,000
Avg Vol (3m):88,215
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in GBp.

Comparison

Symbol% ChgMkt Cap
ASM.LDown 8.57%N/A
SDR.LUp 1.44%7.08B
SDRC.LUp 1.62%5.95B
HL.LUp 0.87%4.63B
ADN.LUp 0.03%4.31B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-13) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Antisoma Plc does not have significant operations. It intends to evaluate various new commercial and acquisition opportunities. Previously, the company was engaged in the development of novel drugs for the treatment of cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback